SHWGY (Shandong Weigao Group Medical Polymer Co) ROCE %: 6.24% (As of Dec. 2025)


SHWGY Shandong Weigao Group Medical Polymer Co Ltd SHWGY
70 GF Score
Price $1.58
GF Value $3.17
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shandong Weigao Group Medical Polymer Co ROCE %?

Shandong Weigao Group Medical Polymer Co SHWGY 70 ROCE % is 6.24% as of Dec. 2025. GuruFocus rates SHWGY with a GF Score™ of 70/100 and a GF Value™ of $3.17 (Significantly Undervalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shandong Weigao Group Medical Polymer Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 6.24%.

Shandong Weigao Group Medical Polymer Co  (OTCPK:SHWGY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shandong Weigao Group Medical Polymer Co ROCE % Related Terms

Shandong Weigao Group Medical Polymer Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Group Medical Polymer Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Group Medical Polymer Co ROCE % Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.54 12.96 9.76 10.14 7.84

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.77 10.86 9.12 9.12 6.24
SHWGY
70GF Score
Shandong Weigao Group Medical Polymer Co Ltd SHWGY
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Group Medical Polymer Co ROCE % Calculation

Shandong Weigao Group Medical Polymer Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=324.76/( ( (4774.245 - 835.154) + (5118.143 - 776.974) )/ 2 )
=324.76/( (3939.091+4341.169)/ 2 )
=324.76/4140.13
=7.84 %

Shandong Weigao Group Medical Polymer Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=268.25/( ( (5033.452 - 773.775) + (5118.143 - 776.974) )/ 2 )
=268.25/( ( 4259.677 + 4341.169 )/ 2 )
=268.25/4300.423
=6.24 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.24% mean?
Shandong Weigao Group Medical Polymer Co (SHWGY) has a ROCE % of 6.24% as of Dec. 2025.
Is Shandong Weigao Group Medical Polymer Co's ROCE % too high?
Shandong Weigao Group Medical Polymer Co's current ROCE % is 6.24%. The Medical Devices & Instruments industry median ROCE % is 2.23. Shandong Weigao Group Medical Polymer Co's value of 6.24% is 179.8% above this industry median. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's ROCE % compare to ISRG and BDX?
Shandong Weigao Group Medical Polymer Co's ROCE % of 6.24% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Shandong Weigao Group Medical Polymer Co's value of 6.24% is 179.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Group Medical Polymer Co's current ROCE % of 6.24% is 179.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Group Medical Polymer Co's current ROCE % is 6.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.17, compared to a current price of $1.58 — trading 50.2% below its estimated fair value. The current ROCE % is 6.24% and 179.8% above the Medical Devices & Instruments industry median of 2.23. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current ROCE % is 6.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued. The current stock price of $1.58 is trading 50.2% below its estimated GF Value™ of $3.17. GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.

Key valuation signals for SHWGY:

  • ROCE %: 6.24%
  • GF Value™: $3.17 vs. price of $1.58 (50.2% below fair value)
  • GF Score™: 70/100 with 7 warning signs
  • Industry Position: 179.8% above the Medical Devices & Instruments median

No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Weigao Group Medical Polymer Co Business Description

Address No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
70GF Score

Get the complete analysis for SHWGY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.58
Price
$3.17
GF Value